Drug intelligence / Profile preview

cerastes vipera venom

Development stage
Preclinical
Lead developer
Tanta University
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Intravenous, Intratumoral
01

Overview

Cerastes vipera venom is a complex biological mixture derived from the Sahara Sand Viper (also known as the Egyptian Sand Viper), native to North Africa and the Middle East. It is currently being investigated for its potential as an antineoplastic agent, demonstrating significant in vitro cytotoxicity against breast cancer (MCF-7) and hepatocellular carcinoma (HepG2) cell lines. The venom's mechanism of action is primarily driven by the induction of oxidative stress, leading to increased lipid peroxidation and the depletion of antioxidant defenses like glutathione. This oxidative damage results in mitochondrial dysfunction, characterized by the loss of mitochondrial membrane potential and the release of pro-apoptotic factors such as Cytochrome C, ultimately triggering programmed cell death. A specific bioactive component, L-amino acid oxidase (Cv-LAAOI), has been isolated from the venom and identified as a potent inducer of apoptosis in various cancer models.

Other names
Sahara Sand Viper venomEgyptian Sand Viper venomC. vipera venom
02

Targets

Neuraminidase

Beyond the preview

Go deeper on cerastes vipera venom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cerastes vipera venom.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call